Evidence map›Paper›PMID 35199643›Full record

ArticleeLife2022

Complex effects of kinase localization revealed by compartment-specific regulation of protein kinase A activity.

Rebecca LaCroix, Benjamin Lin, Tae-Yun Kang, Andre Levchenko

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Rebecca LaCroixDepartment of Biomedical Engineering, Yale University, New Haven, United States.
Benjamin LinDepartment of Biomedical Engineering, Yale University, New Haven, United States.
Tae-Yun KangDepartment of Biomedical Engineering, Yale University, New Haven, United States.
Andre LevchenkoDepartment of Biomedical Engineering, Yale University, New Haven, United States.ORCID 0000-0001-6262-1222
Yale University · US

Funding

Systems analysis of phenotypic switch in control of cancer invasionU54CA209992 · NCI · YALE UNIVERSITY · PI LEVCHENKO, ANDRE · 2016 to 2021
$10.1M
NCI NIH HHS U54 CA209992
6 · The paper itself

Abstract

Kinase activity in signaling networks frequently depends on regulatory subunits that can both inhibit activity by interacting with the catalytic subunits and target the kinase to distinct molecular partners and subcellular compartments. Here, using a new synthetic molecular interaction system, we show that translocation of a regulatory subunit of the protein kinase A (PKA-R) to the plasma membrane has a paradoxical effect on the membrane kinase activity. It can both enhance it at lower translocation levels, even in the absence of signaling inputs, and inhibit it at higher translocation levels, suggesting its role as a linker that can both couple and decouple signaling processes in a concentration-dependent manner. We further demonstrate that superposition of gradients of PKA-R abundance across single cells can control the directionality of cell migration, reversing it at high enough input levels. Thus, complex in vivo patterns of PKA-R localization can drive complex phenotypes, including cell migration.

Indexed as

Cell MembraneCell MovementCell PolarityCyclic AMPCyclic AMP-Dependent Protein KinasesHeLa CellsHumansPhosphorylationProtein TransportSignal TransductionSirolimusTacrolimus Binding ProteinsCyclic AMPCyclic AMP-Dependent Protein KinasesSirolimusTacrolimus Binding Proteinsbiochemistrycell migrationchemical biologyFRETkinase activitymicrofluidicsnonephysics of living systemsPKAsignal transduction

Identifiers

PMID35199643
PMCPMC8871369
OpenAlexW4221100175

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.